Virta's Diabetes Reversal Model
Virta Health
Virta is selling a clinical intervention, not a tracking app. The difference is that the goal is to get a member off insulin and other diabetes drugs by changing the biology driving high blood sugar, which requires daily coach contact, connected meters, physician medication changes, and tight screening for who can safely follow a very low carb protocol. That higher intensity lets Virta charge more and tie fees to outcomes.
-
Traditional programs like Livongo and Omada are built more around ongoing management, medication adherence, and lifestyle support across large employer populations. Virta goes after a narrower group of members, but at about $2.8K per diabetes patient per year versus roughly $1K for management programs, with average revenue per customer about 2 times Omada.
-
The reversal promise only works because Virta wraps diet change in real clinical operations. Members use a glucose meter, ketone meter, and scale, check in with coaches 2 to 4 times per day, and physicians adjust medications as blood sugar improves. In Virta's reported two year results, 91% of insulin users reduced or eliminated insulin, and 67% of diabetes specific prescriptions were discontinued among retained participants.
-
That model also explains why Virta screens patients more tightly than a standard coaching app. A keto based treatment can quickly change glucose levels for people on insulin, so safety and outcomes depend on selecting members who still have enough pancreatic function and do not have complicating conditions. The payoff for employers is lower drug spend and medical claims, with Virta reporting more than $10K in savings over two years.
The next phase is turning reversal from a diabetes niche into a broader metabolic care wedge. As employers and health plans look for cheaper alternatives or off ramps to long term GLP-1 use, Virta's high touch model can extend from diabetes into obesity, prediabetes, and adjacent insulin resistance conditions, while keeping its core advantage in outcomes that are hard for lighter weight app based programs to match.